AnaptysBio, Inc. (ANAB)
53.08
-1.82
(-3.32%)
USD |
NASDAQ |
Feb 13, 16:00
53.13
+0.05
(+0.09%)
Pre-Market: 20:00
AnaptysBio Total Assets (Quarterly) : 353.10M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 488.95M |
| Nektar Therapeutics | 301.35M |
| Rigel Pharmaceuticals, Inc. | 242.53M |
| CorMedix, Inc. | 750.86M |
| Verastem, Inc. | 176.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 382.51M |
| Shareholders Equity (Quarterly) | -29.42M |
| Debt to Equity Ratio | -11.78 |
| Current Ratio | 8.678 |
| Net Debt Paydown Yield | 0.77% |